Transcriptional re-programming of liver-resident iNKT cells into T-regulatory type-1-like liver iNKT cells involves extensive gene de-methylation

Front Immunol. 2024 Sep 9:15:1454314. doi: 10.3389/fimmu.2024.1454314. eCollection 2024.

Abstract

Unlike conventional CD4+ T cells, which are phenotypically and functionally plastic, invariant NKT (iNKT) cells generally exist in a terminally differentiated state. Naïve CD4+ T cells can acquire alternative epigenetic states in response to different cues, but it remains unclear whether peripheral iNKT cells are epigenetically stable or malleable. Repetitive encounters of liver-resident iNKT cells (LiNKTs) with alpha-galactosylceramide (αGalCer)/CD1d-coated nanoparticles (NPs) can trigger their differentiation into a LiNKT cell subset expressing a T regulatory type 1 (TR1)-like (LiNKTR1) transcriptional signature. Here we dissect the epigenetic underpinnings of the LiNKT-LiNKTR1 conversion as compared to those underlying the peptide-major histocompatibility complex (pMHC)-NP-induced T-follicular helper (TFH)-to-TR1 transdifferentiation process. We show that gene upregulation during the LINKT-to-LiNKTR1 cell conversion is associated with demethylation of gene bodies, inter-genic regions, promoters and distal gene regulatory elements, in the absence of major changes in chromatin exposure or deposition of expression-promoting histone marks. In contrast, the naïve CD4+ T cell-to-TFH differentiation process involves extensive remodeling of the chromatin and the acquisition of a broad repertoire of epigenetic modifications that are then largely inherited by TFH cell-derived TR1 cell progeny. These observations indicate that LiNKT cells are epigenetically malleable and particularly susceptible to gene de-methylation.

Keywords: epigenetics; gene de-methylation; iNKT cell; iNKT cell re-programming; liver iNKT cell; liver iNKT-regulatory type-1 (LiNKTR1) cells; αGalCer/CD1d-coated nanoparticles.

MeSH terms

  • Animals
  • Antigens, CD1d / genetics
  • Antigens, CD1d / metabolism
  • Cell Differentiation / genetics
  • DNA Methylation*
  • Epigenesis, Genetic*
  • Galactosylceramides
  • Liver* / cytology
  • Liver* / immunology
  • Liver* / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Natural Killer T-Cells* / immunology
  • Natural Killer T-Cells* / metabolism
  • T-Lymphocytes, Regulatory / immunology
  • T-Lymphocytes, Regulatory / metabolism
  • Transcription, Genetic

Substances

  • Galactosylceramides
  • alpha-galactosylceramide
  • Antigens, CD1d

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported in part by Genome Canada and Genome Alberta (GAPP program), the Canadian Institutes of Health Research (CIHR) (FDN-353029, PJT-479040, PJT-479038, FRN-168480 (with JDRF), DT4-179512), the European Union (HORIZON-HLTH-2022, project 101076383 — PHOENIX —), Ministerio de Ciencia e Innovación of Spain (MCIN; PID2021-125493OB-I00), Generalitat de Catalunya (SGR and CERCA Programmes) and Red Española de Supercomputación (RES, providing CSUC resources). JM, JG and PS were supported by predoctoral studentship from FPU (MINECO). PSe was an investigator of the Ramon y Cajal re-integration program and was supported by a JDRF Career Development Award.